BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6267625)

  • 1. Feeding elicited by injection of the cholecystokinin antagonist dibutyryl cyclic GMP into the cerebral ventricles of sheep.
    Della-Fera MA; Baile CA; Peikin SR
    Physiol Behav; 1981 May; 26(5):799-801. PubMed ID: 6267625
    [No Abstract]   [Full Text] [Related]  

  • 2. Dibutyryl cyclic GMP, a competitive inhibitor of cholecystokinin/pancreozymin and related peptides in the gallbladder and ileum.
    Davison JS; Najafi-Farashah A
    Can J Physiol Pharmacol; 1981 Oct; 59(10):1100-4. PubMed ID: 6274490
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of the action of cholecystokinin octapeptide on the guinea pig ileum myenteric plexus by dibutyryl cyclic guanosine monophosphate.
    Hutchison JB; Dockray GJ
    Brain Res; 1980 Dec; 202(2):501-5. PubMed ID: 6254616
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of dibutyryl cyclic GMP on the content of biogenic amines in discrete areas of brain and on the behaviour of rats.
    Herman ZS; Kmieciak-KoĊ‚ada K
    Med Biol; 1978 Jun; 56(3):128-32. PubMed ID: 210334
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of third cerebral ventricular injections of cyclic guanosine nucleotides on body temperature of cats.
    Clark WG
    Proc Soc Exp Biol Med; 1978 Sep; 158(4):655-7. PubMed ID: 211521
    [No Abstract]   [Full Text] [Related]  

  • 6. A soluble interaction between dibutyryl cyclic guanosine 3':5'-monophosphate and cholecystokinin: a possible mechanism for the inhibition of cholecystokinin activity.
    Miller LJ; Reilly WM; Rosenzweig SA; Jamieson JD; Go VL
    Gastroenterology; 1983 Jun; 84(6):1505-11. PubMed ID: 6301926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of cholecystokinin-induced persistent stimulation of pancreatic enzyme secretion by dibutyryl cyclic GMP.
    Collins SM; Abdelmoumene S; Jensen RT; Gardner JD
    Am J Physiol; 1981 Jun; 240(6):G466-71. PubMed ID: 6166201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of dibutyryl cyclic guanosine monophosphate, a competitive antagonist to cholecystokinin-pancreozymin, on gastric acid secretion in the isolated mouse stomach.
    Davison JS; Najafi-Farashah A
    Life Sci; 1982 Jul; 31(4):355-61. PubMed ID: 6128663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of the effects of carbachol, eserine and dibutyryl cyclic guanosine monophosphate on the behaviour of the cat].
    Samardzic R; Varagic V; Beleslin D
    C R Seances Soc Biol Fil; 1980; 174(2):132-5. PubMed ID: 6249467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of cyclic GMP on rodent aggressive behavior.
    Kantak KM; Hegstrand LR; Eichelman B
    Life Sci; 1981 Sep; 29(13):1379-85. PubMed ID: 6270485
    [No Abstract]   [Full Text] [Related]  

  • 11. Dibutyryl cGMP: inhibitor of the effect of cholecystokinin and gastrin on the guinea pig gallbladder in vitro.
    Poitras P; Iacino D; Walsh JH
    Biochem Biophys Res Commun; 1980 Sep; 96(1):476-82. PubMed ID: 6254515
    [No Abstract]   [Full Text] [Related]  

  • 12. Opposing actions of dibutyryl cyclic AMP and GMP on temperature in conscious guinea-pigs.
    Kandasamy SB; Williams BA
    Neuropharmacology; 1983 Jan; 22(1):65-70. PubMed ID: 6302546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin inhibits gastrin release induced by antral infusion of cyclic nucleotides and bombesin in the pig.
    Linehan WM; Cooper CW; Wells SA
    Surg Forum; 1979; 30():337-8. PubMed ID: 231849
    [No Abstract]   [Full Text] [Related]  

  • 14. Inactivation of cholecystokinin receptors in rat pancreatic membranes by sulfhydryl reagents: protection by guanosine 5'-triphosphate (GTP) but not N2,O2-dibutyryl guanosine 3',5'-cyclic monophosphate (dibutyryl cGMP).
    Chang RS; Lotti VJ; Chen TB
    Biochem Pharmacol; 1984 Jul; 33(14):2334-5. PubMed ID: 6087823
    [No Abstract]   [Full Text] [Related]  

  • 15. The mechanisms by which dibutyryl cyclic GMP antagonizes the action of cholecystokinin.
    Miller LJ; Reilly WM; Rosenzweig SA; Jamieson JD; Go VL
    Gastroenterology; 1983 Jun; 84(6):1637-9. PubMed ID: 6301928
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemodynamic effects of dibutyryl cyclic GMP in anesthetized dogs.
    Imura K; Ogawa K; Satake T
    Basic Res Cardiol; 1986; 81(3):276-82. PubMed ID: 3019295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butyryl derivatives of cyclic GMP interfere with the biological and the immunological properties of the pancreozymin-gastrin family of peptides.
    Robberecht P; Deschodt-Lanckman M; Woussen-Colle MC; De Neef P; Camus JC; Christophe J
    Mol Pharmacol; 1980 Mar; 17(2):268-74. PubMed ID: 6156397
    [No Abstract]   [Full Text] [Related]  

  • 18. Antinociceptive action of the butyryl derivatives of cyclic guanosine 3':5'-monophosphate.
    Vocci FJ; Petty SK; Dewey WL
    J Pharmacol Exp Ther; 1978 Dec; 207(3):892-8. PubMed ID: 215745
    [No Abstract]   [Full Text] [Related]  

  • 19. Analgesia following local injection of dibutyryl cyclic nucleotides at sites in the rat CNS.
    Levy RA; Goldstein BD; Elyjiw MM
    Eur J Pharmacol; 1981 Apr; 71(1):139-42. PubMed ID: 6263647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism by which dibutyryl cyclic guanosine monophosphate antagonizes the action of cholecystokinin.
    Gardner JD
    Gastroenterology; 1983 Jun; 84(6):1619-21. PubMed ID: 6301927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.